Hipra Scientific, S.L.U
Quick facts
Phase 2 pipeline
- BIMERVAX · Infectious Diseases
BIMERVAX is designed to stimulate an immune response against specific pathogens or antigens. - Comirnaty Omicron XBB1.5
- COVID-19 Vaccine HIPRA
- PHH-1V
- PHH-1V81
- SIIV
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: